Loopback
Loopback Analytics, founded by Neil Smiley, is a Dallas-based healthcare data company specializing in bridging health systems and life sciences organizations to improve specialty care access and outcomes.
Profile
Connects hospitals and drug manufacturers with data tools to improve specialty medication access and patient outcomes.
Loopback Analytics, founded by Neil Smiley, is a Dallas-based healthcare data company specializing in bridging health systems and life sciences organizations to improve specialty care access and outcomes. Initially focusing on health system pharmacies since 2017, the company has grown into a leader in data-driven solutions for specialty and ambulatory pharmacy programs. As of 2025, Loopback serves over 90 academic medical centers and integrated delivery networks (IDNs), encompassing 800+ hospitals and processing 90 million prescription fills annually.
The company has been recognized for rapid growth, earning spots on both the Dallas Business Journal's Fast 50 list and the Inc. 5000 list for two consecutive years. Its revenue trajectory reflects expanding partnerships with health systems and life sciences manufacturers, though specific financials remain undisclosed. Recent strategic hires like Elizabeth Cherry as VP of Access Solutions signal continued focus on scaling market access capabilities. What's notable now is Loopback's dual role: enabling health systems to optimize specialty pharmacy operations while providing life sciences companies with real-world data for evidence generation and patient access strategies.
Who buys this
- Health system specialty pharmacy leaders seeking operational optimization
- Life sciences researchers requiring real-world patient data cohorts
- Pharmaceutical commercial teams designing market access strategies
- Integrated delivery networks (IDNs) demonstrating clinical value
- Payors and providers collaborating on specialty care pathways
Publicly disclosed clients
- Ballad Health
Strengths and what to watch
Strengths
- National network covering 90+ IDNs with 92% average medication adherence rates (PDC)
- Recurring recognition on Fast 50 and Inc. 5000 lists validates revenue growth trajectory
- Dual-sided platform moat: health system data partnerships attract life sciences customers
Watch for
- Dependence on specialty pharmacy growth—a market facing reimbursement pressures
- Client concentration risk with ~30 disclosed health system partners
- No disclosed funding rounds; unclear capital structure for scaling
Recent moves
Key Information
- Founded
- 2009
- Headquarters
- Dallas
Frequently Asked Questions
What does Loopback Analytics do?
Loopback Analytics connects hospitals and drug manufacturers with data tools to improve specialty medication access. The Dallas-based company helps health systems optimize pharmacy operations while providing life sciences firms with real-world patient data. It serves 90+ medical centers processing 90 million annual prescriptions.
How does Loopback help specialty pharmacies?
Loopback's platform helps health system pharmacies improve medication adherence (92% average rate) and operational efficiency. Their data tools connect 800+ hospitals, enabling better patient access to specialty drugs while generating actionable insights for pharmacy leaders managing complex therapies.
What types of organizations work with Loopback?
Loopback serves academic medical centers, IDNs, and life sciences companies. Notable clients include Ballad Health. Their dual platform benefits health systems managing specialty pharmacies and pharmaceutical firms needing real-world data for market access strategies and evidence generation.
Why is Loopback growing so fast?
Loopback's consecutive appearances on Dallas Fast 50 and Inc. 5000 lists reflect rapid growth. Their success stems from bridging health systems and drug manufacturers - serving 30+ partners with data solutions that improve medication access while demonstrating clinical and financial value.
What results does Loopback deliver for hospitals?
Loopback helps hospital pharmacies achieve 92% average medication adherence rates across their network. Their tools optimize specialty drug access for 800+ hospitals while providing data to demonstrate program value to health system administrators and payors.
How does Loopback work with drug manufacturers?
Loopback provides pharmaceutical companies with de-identified patient data from 90+ medical centers. This real-world evidence helps manufacturers understand medication access barriers, demonstrate treatment value, and design effective market access strategies for specialty therapies.
Sources
- www.prnewswire.com — 2025 Fast 50 recognition and health system network metrics
- www.prnewswire.com — Inc. 5000 listing and CEO growth commentary
- www.prnewswire.com — Ballad Health partnership case study
- www.prnewswire.com — Historical client count baseline (30+ as of 2021)